SEC Tracker
Get the app

Autolus Therapeutics AUTL

Autolus Therapeutics (BX) updates ownership details.

Schedule 13D/A on Autolus Therapeutics (AUTL), filed with the SEC on Nov 10, 2026, 4:30 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by Blackstone Inc. (amended)

Form
Schedule 13D/A
Filed
Importance
Notable
  1. Amendment No. 3 updates ownership of Ordinary Shares and ADSs.
  2. No new purchases or dispositions by Reporting Persons.
  3. Blackstone Entities are the main reporting parties.
  4. Warrants expiration caused ownership changes.

Written from the Schedule 13D/A on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Autolus Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.